← All stocks

InMed Pharmaceuticals Inc.

INM Net buying
CIK 0001728328 #5290 in the set updated 17 Sep 2026
Bought (120 mo)
$1.40M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$42.31
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$42.31
1 of 1 sales
Net
+$1.40M
+$1.40M against sales at will

By person

7 insiders · 49 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ADAR1 Capital Management, LLC entity
10% owner
$841.18K (7)
+$841.18K
1,693,101
$2.18M
+49.5%
Vivo Opportunity, LLC entity
10% owner
$433.55K (30)
+$433.55K
75,019
$96.70K
ADAMS ERIC A
President & CEO
$70.07K (5)
+$70.07K
43,959
$56.66K
Johnson Shane Aaron
Sr VP & General Manager
$28.29K (3)
+$28.29K
304,595
$392.62K
+7.6%
HULL ANDREW
Director
$14.63K (1)
+$14.63K
38,258
$49.31K
+4,947%
COLWILL BRUCE
CFO
$14.28K (2)
+$14.28K
11,515
$14.84K
+660.1%
MANCINI ALEXANDRA DIANE JANET
Consultant
$42.31 (1)
−$42.31
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 11.1 over the window, from 1,207,186 to 13,340,245 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
MANCINI ALEXANDRA DIANE JANET
31 Jul 2024
Consultant
Sell
240
$0.18
$42.31

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 18 Dec 2020